Latest results FY2026 · Prices updated Oct 30, 2026
HQ: TokyoFounded 1923185 employeesWebsite
A leading Japanese pharmaceutical wholesale group. It supports medical infrastructure through advanced logistics and information systems, centered on its core subsidiary Mediceo.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Prescription Drug Wholesale Business | 65% | ¥2.5T | ¥24.3B | 1.0% |
| Cosmetics, Daily Goods and OTC Drug Wholesale | 32% | ¥1.2T | ¥26.4B | 2.1% |
| Animal Medicine and Food Ingredient Wholesale | 3% | ¥117.3B | ¥2.3B | 2.0% |
Close (Oct 30, 2026)
¥3,441+37.9% (1Y)
Medipal +37.9% over 1Y, 11.7pt above the industry average (34 companies, +26.2%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥3.8T | ¥53.2B | ¥42.5B | ¥1.9T | +4.0% |
| 2025FY | ¥3.7T | ¥55.6B | ¥40.3B | ¥1.8T | +3.2% |
| 2024FY | ¥3.6T | ¥47.3B | ¥41.5B | ¥1.8T | +5.9% |
| 2023FY | ¥3.4T | ¥49.0B | ¥38.8B | ¥1.7T | +2.1% |
| 2022FY | ¥3.3T | ¥45.6B | ¥29.4B | ¥1.7T | +2.5% |
| 2021FY | ¥3.2T | ¥38.6B | ¥23.9B | ¥1.7T | — |
Sources: annual securities reports, earnings releases and other public disclosures (Dec 2024)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
